Literature DB >> 25965903

Microparticles: Bridging the Gap between Autoimmunity and Thrombosis.

Elena Niccolai1, Giacomo Emmi1, Danilo Squatrito1, Elena Silvestri1, Lorenzo Emmi2, Amedeo Amedei1, Domenico Prisco1.   

Abstract

Microparticles (MPs) are irregularly shaped small vesicles of heterogeneous size released from the plasma membrane in a tightly controlled process, after different stimuli. MPs have been associated with proinflammatory effects and also with autoimmune processes, being a source of autoantigenic nuclear material, which can form immune complexes. In addition, recent reports have linked a large number of autoimmune disorders to an increased risk of thrombosis, and MPs seem to promote the potential for thrombotic events. A growing mass of evidence supports the idea that MPs could contribute to the generation of an inflammation-induced hypercoagulability state, having a relevant role in the pathogenesis of the thrombotic phenomena associated to autoimmune disease, such as systemic lupus erythematosus, antiphospholipid antibody syndrome, and systemic vasculitis. In this review, we focus on the procoagulant properties of circulating MPs and analyze their contribution to the pathogenesis of autoimmune diseases. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25965903     DOI: 10.1055/s-0035-1549850

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  15 in total

Review 1.  Extracellular vesicles as mediators of vascular inflammation in kidney disease.

Authors:  Alexandra Helmke; Sibylle von Vietinghoff
Journal:  World J Nephrol       Date:  2016-03-06

Review 2.  Extracellular vesicles in autoimmune vasculitis - Little dirts light the fire in blood vessels.

Authors:  Xiuhua Wu; Yu Liu; Wei Wei; Ming-Lin Liu
Journal:  Autoimmun Rev       Date:  2019-04-05       Impact factor: 9.754

Review 3.  The antiphospholipid syndrome: from pathophysiology to treatment.

Authors:  Simone Negrini; Fabrizio Pappalardo; Giuseppe Murdaca; Francesco Indiveri; Francesco Puppo
Journal:  Clin Exp Med       Date:  2016-06-22       Impact factor: 3.984

Review 4.  Recent advances in Extracellular Vesicles and their involvements in vasculitis.

Authors:  Nan Yang; Yin Zhao; Xiuhua Wu; Na Zhang; Haoming Song; Wei Wei; Ming-Lin Liu
Journal:  Free Radic Biol Med       Date:  2021-05-02       Impact factor: 8.101

5.  Thrombosis in vasculitis: from pathogenesis to treatment.

Authors:  Giacomo Emmi; Elena Silvestri; Danilo Squatrito; Amedeo Amedei; Elena Niccolai; Mario Milco D'Elios; Chiara Della Bella; Alessia Grassi; Matteo Becatti; Claudia Fiorillo; Lorenzo Emmi; Augusto Vaglio; Domenico Prisco
Journal:  Thromb J       Date:  2015-04-16

Review 6.  A Dormant Microbial Component in the Development of Preeclampsia.

Authors:  Douglas B Kell; Louise C Kenny
Journal:  Front Med (Lausanne)       Date:  2016-11-29

Review 7.  Recent Progress in Research on the Pathogenesis of Pulmonary Thromboembolism: An Old Story with New Perspectives.

Authors:  Chao Yan; Xiaohua Wang; Hua Su; Kejing Ying
Journal:  Biomed Res Int       Date:  2017-04-06       Impact factor: 3.411

8.  A Case of Miller Fisher Syndrome, Thromboembolic Disease, and Angioedema: Association or Coincidence?

Authors:  Nooshin Salehi; Eric D Choi; Roger C Garrison
Journal:  Am J Case Rep       Date:  2017-01-16

9.  Optimization of quantitative proteomic analysis of clots generated from plasma of patients with venous thromboembolism.

Authors:  Aneta Stachowicz; Jakub Siudut; Maciej Suski; Rafał Olszanecki; Ryszard Korbut; Anetta Undas; Jacek R Wiśniewski
Journal:  Clin Proteomics       Date:  2017-11-28       Impact factor: 3.988

10.  Procoagulant microparticles are associated with arterial disease in patients with systemic lupus erythematosus.

Authors:  Miguel Angel Plasín-Rodríguez; Patricia Patricio; Joan Monteagudo; Angeles García-Criado; Ricard Cervera; Joan Carles Reverter; Gerard Espinosa; Dolors Tàssies
Journal:  J Thromb Thrombolysis       Date:  2020-10-03       Impact factor: 2.300

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.